Safety and Targeting of Anti-hk2 Antibody in mCRPC

计划入组 27 人 · 首次发布于 2019 年 10 月 4 日

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

计划入组 144 人 · 首次发布于 2020 年 11 月 25 日

Efficacy of Iodine Complex Against COVID-19 Patients

计划入组 200 人 · 首次发布于 2020 年 7 月 16 日

HK2-VDAC modulators (ViDAC Pharma)

BQ-Complex

Gastropylor Complex

HAYATABAD MEDICAL COMPLEX

Pakistan

SALMANIYA MEDICAL COMPLEX

Bahrain

MARDAN MEDICAL COMPLEX

Pakistan

Vidac Pharma to Explore Potential Collaboration with Johnson & Johnson in Intratumoral Oncology

Vidac Pharma Secures Broad U.S. Patent Protection for Novel Mitochondria-Targeted Cancer Therapy

Vidac Pharma Secures USPTO Patent for Novel Hexokinase 2-Mitochondrial Interaction Modulators